{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:43:52Z","timestamp":1762609432952},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,26]]},"DOI":"10.7759\/cureus.42491","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T17:30:23Z","timestamp":1690392623000},"source":"Crossref","is-referenced-by-count":1,"title":["Reversible Dysphagia Associated With Risperidone Presenting With a Choking Episode"],"prefix":"10.7759","author":[{"given":"Shradha","family":"Pandit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Mahat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v59n0205","article-title":"The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics","volume":"59","author":"Miller CH","year":"1998","unstructured":"Miller CH, Mohr F, Umbricht D, et al.. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. J Clin Psychiatry. 1998, 59:69-75.","journal-title":"J Clin Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199819010-00005","article-title":"Managing antipsychotic-induced acute and tardive dystonia","volume":"19","author":"Raja M","year":"1998","unstructured":"Raja M. Managing antipsychotic-induced acute and tardive dystonia. Drug Saf. 1998, 19:57-72. 10.2165\/00002018-199819010-00005","journal-title":"Drug Saf"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00242-X","article-title":"The current status of tardive dystonia","volume":"45","author":"Adityanjee","year":"1999","unstructured":"Adityanjee, Aderibigbe YA, Jampala VC, Mathews T. The current status of tardive dystonia. Biol Psych. 1999, 45:715-30. 10.1016\/S0006-3223(98)00242-X","journal-title":"Biol Psych"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v10n0213b","article-title":"Risperidone-induced tardive pharyngeal dystonia presenting with persistent Dysphagia: a case report","volume":"10","author":"Duggal HS","year":"2008","unstructured":"Duggal HS, Mendhekar DN. Risperidone-induced tardive pharyngeal dystonia presenting with persistent Dysphagia: a case report. Prim Care Companion J Clin Psychiatry. 2008, 10:161-2. 10.4088\/pcc.v10n0213b","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref5","article-title":"Risperidone and dysphagia","volume":"52","author":"Varghese ST","year":"2006","unstructured":"Varghese ST, Balhara YP, George SA, Sagar R. Risperidone and dysphagia. J Postgrad Med. 2006, 52:327-8.","journal-title":"J Postgrad Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-8343(01)00145-1","article-title":"Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?","volume":"23","author":"Nair S","year":"2001","unstructured":"Nair S, Saeed O, Shahab H, Sedky K, Garver D, Lippmann S. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?. Gen Hosp Psychiatry. 2001, 23:231-2. 10.1016\/s0163-8343(01)00145-1","journal-title":"Gen Hosp Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/PL00009533","article-title":"Neuroleptic-induced dysphagia","volume":"12","author":"Sokoloff LG","year":"1997","unstructured":"Sokoloff LG, Pavlakovic R. Neuroleptic-induced dysphagia. Dysphagia. 1997, 12:177-9. 10.1007\/PL00009533","journal-title":"Dysphagia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2001.49249.x","article-title":"Reversible dysphagia associated with neuroleptic treatment","volume":"49","author":"Stewart JT","year":"2001","unstructured":"Stewart JT. Reversible dysphagia associated with neuroleptic treatment. J Am Geriatr Soc. 2001, 49:1260-1. 10.1046\/j.1532-5415.2001.49249.x","journal-title":"J Am Geriatr Soc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/070674379704200509","article-title":"Choking incidents among psychiatric patients: retrospective analysis of thirty-one cases from the west Bologna psychiatric wards","volume":"42","author":"Fioritti A","year":"1997","unstructured":"Fioritti A, Giaccotto L, Melega V. Choking incidents among psychiatric patients: retrospective analysis of thirty-one cases from the west Bologna psychiatric wards. Can J Psychiatry. 1997, 42:515-20. 10.1177\/070674379704200509","journal-title":"Can J Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-003-0006-x","article-title":"Dysphagia associated with risperidone therapy","volume":"18","author":"Stewart JT","year":"2003","unstructured":"Stewart JT. Dysphagia associated with risperidone therapy. Dysphagia. 2003, 18:274-5. 10.1007\/s00455-003-0006-x","journal-title":"Dysphagia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000983","article-title":"Antipsychotic medication and oropharyngeal dysphagia: systematic review","volume":"29","author":"Miarons Font M","year":"2017","unstructured":"Miarons Font M, Rofes Salsench L. Antipsychotic medication and oropharyngeal dysphagia: systematic review. Eur J Gastroenterol Hepatol. 2017, 29:1332-9. 10.1097\/MEG.0000000000000983","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ppc.12062","article-title":"Biological perspectives: choking and antipsychotics: is this a significant concern?","volume":"50","author":"Visser HK","year":"2014","unstructured":"Visser HK, Wigington JL, Keltner NL, Kowalski PC. Biological perspectives: choking and antipsychotics: is this a significant concern?. Perspect Psychiatr Care. 2014, 50:79-82. 10.1111\/ppc.12062","journal-title":"Perspect Psychiatr Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.06.004","article-title":"Antipsychotic use and risk of hospitalization or death due to pneumonia in persons with and those without Alzheimer disease","volume":"150","author":"Tolppanen AM","year":"2016","unstructured":"Tolppanen AM, Koponen M, Tanskanen A, et al.. Antipsychotic use and risk of hospitalization or death due to pneumonia in persons with and those without Alzheimer disease. Chest. 2016, 150:1233-41. 10.1016\/j.chest.2016.06.004","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/162783-reversible-dysphagia-associated-with-risperidone-presenting-with-a-choking-episode","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:01Z","timestamp":1707508921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/162783-reversible-dysphagia-associated-with-risperidone-presenting-with-a-choking-episode"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.42491","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,26]]}}}